New research shows significant strides in the battle against lung cancer.
U.S. (Mesothelioma Cancer News) – New research is showing that significant strides are being made in the battle against lung cancer. As reported by HealthDay News, a set of studies shows that advances have been made allowing researchers to identify biomarkers and other aspects of the disease for more targeted treatment development.
Dr. Roy Herbst, chief of thoracic medical oncology at the University of Texas M. D. Anderson Cancer Center in Houston, is quoted in the report as stating, “Lung cancer is a very vexing problem. In the U.S., approximately 200,000 people will be diagnosed this year and the sad part of it is almost as many will die… This disease tends to present having already spread, and it’s very heterogenous. If we’re going to make the next hurdle of personalized care, we need to better understand the tumor and use that knowledge to treat patients in more specific, effective and less toxic ways.”
As noted in the report, research was presented this week on advances in lung cancer treatment at a conference sponsored by the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC).